Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C

By Mester J.C.   Twomey T.A.   Tepe E.T.   Bernstein D.I.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 875-883

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

By O'Hagan D.   Goldbeck C.   Ugozzoli M.   Ott G.   Burke R.L.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2229-2236

Elsevier

Access to resources Recommend Favorite

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection

By Bernstein D.I.   Tepe E.R.   Mester J.C.   Arnold R.L.   Stanberry L.R.   Higgins T.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1964-1969

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

By Bourne N.   Milligan G.N.   Schleiss M.R.   Bernstein D.I.   Stanberry L.R.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1230-1234

Elsevier

Access to resources Recommend Favorite